Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease (2011)
- Authors:
- USP affiliated authors: FORLENZA, ORESTES VICENTE - FM ; GATTAZ, WAGNER FARID - FM
- Unidade: FM
- DOI: 10.1016/j.jpsychires.2010.06.002
- Subjects: DOENÇA DE ALZHEIMER; TRANSTORNOS COGNITIVOS; CONTAGEM DE PLAQUETAS; NEUROPSIQUIATRIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of psychiatric research
- ISSN: 0022-3956
- Volume/Número/Paginação/Ano: v. 45, n.2, p. 220-224, 2011
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
FORLENZA, Orestes Vicente et al. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. Journal of psychiatric research, v. 45, n. 2, p. 220-224, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.jpsychires.2010.06.002. Acesso em: 15 mar. 2026. -
APA
Forlenza, O. V., Torres, C. A., Talib, L. L., Paula, V. J. de, Joaquim, H. P. G., Diniz, B. S., & Gattaz, W. F. (2011). Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. Journal of psychiatric research, 45( 2), 220-224. doi:10.1016/j.jpsychires.2010.06.002 -
NLM
Forlenza OV, Torres CA, Talib LL, Paula VJ de, Joaquim HPG, Diniz BS, Gattaz WF. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease [Internet]. Journal of psychiatric research. 2011 ; 45( 2): 220-224.[citado 2026 mar. 15 ] Available from: https://doi.org/10.1016/j.jpsychires.2010.06.002 -
Vancouver
Forlenza OV, Torres CA, Talib LL, Paula VJ de, Joaquim HPG, Diniz BS, Gattaz WF. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease [Internet]. Journal of psychiatric research. 2011 ; 45( 2): 220-224.[citado 2026 mar. 15 ] Available from: https://doi.org/10.1016/j.jpsychires.2010.06.002 - Low Doses of Lithium Changes PKA, AKT and Tau Protein in Cortical and Hippocampal Neurons Cell Culture
- Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in Alzheimer's disease
- Reduced serum levels of adiponectin in elderly patients with major depression
- Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania
- Diagnosis and biomarkers of predementia in Alzheimer’s disease
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
- Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype
- Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression
- Inhibition of phospolipase A2 modulates glycogen synthase activity and tau phosphorylation in primary cultures of cortical and hippocampal neurons
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
